The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility ...

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

The use of HCQ among patients with SSc appears to be low and is not associated with improvements in hand function or activities of daily living.

Individuals with type 2 diabetes or a higher BMI may face a reduced risk of developing GCA, while a history of cardiovascular disease may increase this risk.

Patients with vs without RA have a higher risk for avoidable hospitalizations for ambulatory care sensitive conditions, particularly heart failure and pulmonary edema.

Osteoboost, a targeted vibration therapy device, is now available to improve bone strength and bone density in postmenopausal women.

Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.

Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination.

Results of the updated systematic review informing the 2024 EULAR recommendations showed that many ARDs are safe to use during pregnancy, lactation, and reproduction.

Among children with Kawasaki disease, RDW-CV was identified as an independent predictor of CAD and was negatively correlated with markers of iron metabolism.

The global burden of atopic dermatitis (AD) in older adults is considerable and is expected to continue increasing to 2050.

Disaggregating race and ethnicity prenatal depression diagnosis data reveals clinical differences, especially among Asian and Hispanic populations.